Labs are receiving increasing faecal calprotectin tests requests since NICE published Diagnostic Guideline 11: ‘Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel’. This recommends faecal calprotectin as a first-line test for patients presenting with gastrointestinal (GI) symptoms indicative of IBS or IBD.
Pam Bowe, team manager in the Department of Biochemistry at the Cumberland Infirmary, describes the evolution of her laboratory procedures to cope with the growing number of faecal calprotectin test requests.
Turbocharging increasing faecal calprotectin tests at Cumberland Infirmary
With a workload escalating five-fold from 40 to 200 faecal calprotectin test requests each month, Pam’s team has kept up with advancing technology and moved their methodology from single lateral flow tests to ELISA and now a high throughput turbidimetric calprotectin assay on their existing cobas 6000 clinical chemistry analyser.
Read the full Article
